Stratos Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Hold	20,796	–	–	0.07%	250
2025 Q4	$1.24M	Sell	20,796 -6,074	-23%	-$331K	0.06%	283
2025 Q3	$1.46M	Sell	26,870 -8,398	-24%	-$480K	0.07%	268
2025 Q2	$1.94M	Sell	35,268 -400	-1%	-$23.6K	0.1%	208
2025 Q1	$2.52M	Sell	35,668 -7,774	-18%	-$523K	0.14%	143
2024 Q4	$2.86M	Sell	43,442 -400	-0.9%	-$26.8K	0.14%	154
2024 Q3	$3.08M	Sell	43,842 -2,022	-4%	-$169K	0.14%	157
2024 Q2	$3.78M	Hold	45,864	–	–	0.19%	122
2024 Q1	$4.01M	Hold	45,864	–	–	0.24%	102
2023 Q4	$4.42M	Hold	45,864	–	–	0.25%	113
2023 Q3	$4.06M	Sell	45,864 -2,550	-5%	-$227K	0.27%	105
2023 Q2	$4.2M	Buy	48,414 +1,600	+3%	+$151K	0.3%	92
2023 Q1	$4.55M	Buy	46,814 +9,755	+26%	+$1.01M	0.35%	79
2022 Q4	$3.84M	Buy	+37,059	New	+$3.48M	0.32%	92